It is of particular importance to reduce extra column volumes when using small volume columns or UHPLC. However, where do these extra column volumes come from, how can they be minimized, and what effect do they have on chromatography?
It is of particular importance to reduce extra column volumes when using small volume columns or UHPLC. However, where do these extra column volumes come from, how can they be minimized, and what effect do they have on chromatography?
Question: If the HPLC system contains a large extra-column volume should it not be that the later eluting peaks are broader and have a higher plate count than the early eluting peaks?
Answer: Firstly, I thought I would detail a couple of definitions in relation to the subject of efficiency and extra column volumes and their effects.
Definitions:
Extra column volume – the volume between the injection point and the detection point, excluding the part of the column containing the stationary phase. It is composed of the injector, connecting lines, frits, and the detector; and it is this that determines the extra column effects.
Extra column effects – the total band broadening effects of all parts of the chromatographic system outside of the column itself. Extra column effects must be minimized to maintain the efficiency of the column. Areas of band broadening can include the injector, injection volume, connecting tubing, end fittings, frits, detector cell volume, and internal detector tubing. The variances of all these contributions are additive.
W = bandwidth
The following are bandwidth contributions from:
Wc = column
Ws = injector/autosampler
Wlc = lines and connectors
Wfc = detector flow cell
As long as the bandwidth contributions Ws, Wlc, and Wfc are each less than 1/3W their effect on W can be neglected.
The complete article is available to CHROMacademy Lite and Premier members here >>
CHROMacademy Lite Membership is FREE and it only takes two minutes to register.
With a Lite Membership you are given access to:
â This month's webcast & tutorial
â Selected eLearning modules
â Featured CHROMacademy Content
â The CHROMacademy forum
Test drive CHROMacademy and Check out more great content available FREE to our Lite members »
Reversed Phase HPLC for the Analysis of Biomolecules
November 15th 2016Biopharmaceuticals offer great hope in treating medical conditions which are currently poorly served, at best, by traditional pharmaceuticals. It is estimated that there are over 400 biopharmaceuticals in clinical trials for in excess of 200 disease areas. The enhanced complexity and variability that comes from the size of biopharmaceuticals, allied with the intricacy of the production process, mean chromatography is employed to a much greater extent during production and release testing. The following article will introduce the fundamentals of biopharmaceutical analysis and cover the use of reversed phase HPLC in the analysis of biomolecules. A subsequent article will detail the application of HILIC, IEX, and SEC chromatography for the analysis if biomolecules.